An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer

Until recently, effective therapies for advanced endometrial cancer progressing to a platinum-based combination were lacking. In this setting, immunotherapy with anti PD-1/PDL-1 monoclonal antibodies is rising as a new paradigm in particular for patients with microsatellites instability/mismatch rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartoletti, Michele, Giorda, Giorgio, Viel, Alessandra, Fornasarig, Mara, Zdjelar, Adrian, Segatto, Enrica, Sorio, Roberto, Corsetti, Serena, Scalone, Simona, Nicoloso, Milena Sabrina, Pivetta, Tania, Lucia, Emilio, Clemente, Nicolò, Palazzari, Elisa, Canzonieri, Vincenzo, Puglisi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332114/
https://www.ncbi.nlm.nih.gov/pubmed/35892982
http://dx.doi.org/10.3390/curroncol29080413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332114/
https://www.ncbi.nlm.nih.gov/pubmed/35892982
http://dx.doi.org/10.3390/curroncol29080413

Ejemplares similares